KLTO-101

N/A

Report date: 2025/03/05 16:02:11

Base Information

Drug NameKLTO-101
Drug Alias NameKLTO-101AAV9.CMV.s-KL
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transference
TargetsUpdating
Therapy Area/IndicationsAlzheimer DiseaseParkinson DiseaseHuntington Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKlotho Neurosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesKlotho Neurosciences Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseParkinson DiseaseHuntington Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A